What are the treatment options for a patient with globus sensation?

Treatment of Globus Sensation

Initiate high-dose proton pump inhibitor (PPI) therapy as first-line treatment for patients with globus sensation after excluding alarm symptoms, as GERD is a major causative factor. 1

Initial Assessment and Red Flag Exclusion

Before starting treatment, you must exclude conditions requiring urgent intervention:

• Weight loss mandates urgent endoscopy to rule out malignancy 1
• Food bolus obstruction requires immediate gastroenterology referral for endoscopic intervention, as eosinophilic esophagitis is found in up to 46% of these cases 1
• Odynophagia (painful swallowing), hemoptysis, fever >101.5°F, or night sweats suggest serious underlying pathology requiring urgent investigation 1
• Palpable lymphadenopathy >1.5 cm, firm, or non-tender requires urgent investigation for malignancy or serious infection 1

Distinguishing Globus from Dysphagia

This distinction is critical as it determines your entire management approach:

• Globus characteristically improves during eating, whereas dysphagia worsens with swallowing 2, 1
• Globus is more prominent between meals and often resolves during food intake 2
• Mistaking globus for dysphagia leads to inappropriate treatment 2, 1
• Approximately 20% of patients may have both conditions, but the predominant pattern guides initial therapy 2

First-Line Treatment: High-Dose PPI Therapy

The American College of Gastroenterology recommends high-dose PPI therapy as first-line treatment given the benign nature of globus and GERD as a major causative factor 1:

• Trial duration must be 8-12 weeks, as effects require this time to manifest 1
• Inadequate trial duration is a common pitfall leading to premature treatment escalation 1
• Globus is commonly associated with extraesophageal reflux manifestations 1

Adjunctive Therapies for PPI-Treated Patients

The American College of Gastroenterology suggests phenotype-based additions to PPI therapy 1:

• Alginate antacids for breakthrough symptoms 1
• Nighttime H2 receptor antagonists for nocturnal symptoms 1
• Baclofen for regurgitation or belch-predominant symptoms 1

Second-Line Treatment: Neuromodulators

For patients who fail adequate PPI therapy (8-12 weeks), consider tricyclic antidepressants as neuromodulators 3:

• Start with low doses (10-25 mg at bedtime) rather than higher doses used in IBS trials, as lower doses appear effective with better tolerability 3
• TCAs work through neuromodulatory effects on visceral hypersensitivity and central pain processing, independent of antidepressant properties 3
• Effects may require several weeks to manifest, so adequate trial duration is essential 3
• TCAs inhibit serotonin and noradrenergic reuptake, modulating visceral sensation and reducing throat discomfort perception 3

Critical distinction: Muscle relaxants like cyclobenzaprine are inappropriate and potentially harmful, as globus is a sensory phenomenon related to pharyngolaryngeal hypersensitivity, not true muscle spasm 3

Speech and Language Therapy

For throat tightening/laryngeal hypersensitivity syndrome (symptoms that do NOT improve with eating), speech and language therapy is the primary recommended intervention 1:

• This addresses aberrant involuntary learned behaviors 1
• Patient education about the functional nature of the disorder is essential 1
• Globus commonly co-occurs with functional voice disorders 2, 1

Multidisciplinary Evaluation When Indicated

The American College of Gastroenterology notes that globus often requires input from multiple specialties 1:

• Otolaryngology for laryngeal evaluation and exclusion of structural pathology (Zenker's diverticulum, pharyngeal cancer) 1, 4
• Gastroenterology for reflux assessment and endoscopic evaluation 1
• Consider esophageal motility testing if PPI-resistant, as 47.9% of such patients have abnormal esophageal motility 4

Psychological Factors

Globus is frequently associated with psychological stress, with many patients reporting symptom exacerbation during high emotional intensity 2, 1:

• Anxiety is found in 34.95% and depression in 12.5% of patients with globus 5
• However, psychological characteristics are unlikely to be etiologically significant and do not predict treatment response 6
• Reassurance about the benign nature and good prognosis is therapeutic 7, 8

Treatment Algorithm Summary

1. Exclude alarm symptoms (weight loss, dysphagia, odynophagia, lymphadenopathy) 1
2. Confirm globus pattern (improves with eating, not dysphagia) 2, 1
3. Start high-dose PPI for 8-12 weeks 1
4. Add phenotype-based adjuncts (alginates, H2RAs, baclofen) as needed 1
5. If PPI-resistant, consider low-dose TCA (10-25 mg at bedtime) 3
6. For throat tightening that doesn't improve with eating, refer for speech therapy 1
7. Consider otolaryngology/gastroenterology evaluation for persistent symptoms 1

Common Pitfalls to Avoid

• Inadequate PPI trial duration (<8-12 weeks) leads to premature treatment changes 1
• Using muscle relaxants instead of neuromodulators is inappropriate for this sensory disorder 3
• Mistaking globus for dysphagia results in wrong diagnostic and treatment pathways 2, 1
• Extensive testing in absence of alarm symptoms is unnecessary and costly 8